<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
  <meta charset="utf-8" />
  <meta name="generator" content="pandoc" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
  <meta name="author" content="hbaolong@vip.qq.com" />
  <title>癌症传EN:An Anatomist’s Tumor</title>
  <style>
    html {
      color: #1a1a1a;
      background-color: #fdfdfd;
    }
    body {
      margin: 0 auto;
      max-width: 36em;
      padding-left: 50px;
      padding-right: 50px;
      padding-top: 50px;
      padding-bottom: 50px;
      hyphens: auto;
      overflow-wrap: break-word;
      text-rendering: optimizeLegibility;
      font-kerning: normal;
    }
    @media (max-width: 600px) {
      body {
        font-size: 0.9em;
        padding: 12px;
      }
      h1 {
        font-size: 1.8em;
      }
    }
    @media print {
      html {
        background-color: white;
      }
      body {
        background-color: transparent;
        color: black;
        font-size: 12pt;
      }
      p, h2, h3 {
        orphans: 3;
        widows: 3;
      }
      h2, h3, h4 {
        page-break-after: avoid;
      }
    }
    p {
      margin: 1em 0;
    }
    a {
      color: #1a1a1a;
    }
    a:visited {
      color: #1a1a1a;
    }
    img {
      max-width: 100%;
    }
    svg {
      height: auto;
      max-width: 100%;
    }
    h1, h2, h3, h4, h5, h6 {
      margin-top: 1.4em;
    }
    h5, h6 {
      font-size: 1em;
      font-style: italic;
    }
    h6 {
      font-weight: normal;
    }
    ol, ul {
      padding-left: 1.7em;
      margin-top: 1em;
    }
    li > ol, li > ul {
      margin-top: 0;
    }
    blockquote {
      margin: 1em 0 1em 1.7em;
      padding-left: 1em;
      border-left: 2px solid #e6e6e6;
      color: #606060;
    }
    code {
      font-family: Menlo, Monaco, Consolas, 'Lucida Console', monospace;
      font-size: 85%;
      margin: 0;
      hyphens: manual;
    }
    pre {
      margin: 1em 0;
      overflow: auto;
    }
    pre code {
      padding: 0;
      overflow: visible;
      overflow-wrap: normal;
    }
    .sourceCode {
     background-color: transparent;
     overflow: visible;
    }
    hr {
      background-color: #1a1a1a;
      border: none;
      height: 1px;
      margin: 1em 0;
    }
    table {
      margin: 1em 0;
      border-collapse: collapse;
      width: 100%;
      overflow-x: auto;
      display: block;
      font-variant-numeric: lining-nums tabular-nums;
    }
    table caption {
      margin-bottom: 0.75em;
    }
    tbody {
      margin-top: 0.5em;
      border-top: 1px solid #1a1a1a;
      border-bottom: 1px solid #1a1a1a;
    }
    th {
      border-top: 1px solid #1a1a1a;
      padding: 0.25em 0.5em 0.25em 0.5em;
    }
    td {
      padding: 0.125em 0.5em 0.25em 0.5em;
    }
    header {
      margin-bottom: 4em;
      text-align: center;
    }
    #TOC li {
      list-style: none;
    }
    #TOC ul {
      padding-left: 1.3em;
    }
    #TOC > ul {
      padding-left: 0;
    }
    #TOC a:not(:hover) {
      text-decoration: none;
    }
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    div.columns{display: flex; gap: min(4vw, 1.5em);}
    div.column{flex: auto; overflow-x: auto;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    /* The extra [class] is a hack that increases specificity enough to
       override a similar rule in reveal.js */
    ul.task-list[class]{list-style: none;}
    ul.task-list li input[type="checkbox"] {
      font-size: inherit;
      width: 0.8em;
      margin: 0 0.8em 0.2em -1.6em;
      vertical-align: middle;
    }
    .display.math{display: block; text-align: center; margin: 0.5rem auto;}
  </style>
</head>
<body>
<header id="title-block-header">
<h1 class="title">癌症传EN:An Anatomist’s Tumor</h1>
<p class="author">hbaolong@vip.qq.com</p>
</header>
<center>
<a href="/3place/azzen">返回首页</a> <a
href="/3place/azzen/mingju.html">本书名句</a> <a
href="/3place/azzen/memo.html">本书注解</a> <a
href="/3place/azzen/index_rich.html">丰富目录</a> <a
href="/3place/azzen/index_readcal.html">同读日历</a> <a
href="/3place/azzen/index_timeline.html">时间线</a> <a
href="/3place/azzen/index_books.html">引用书籍</a> <a
href="/3place/azzen/index_words.html">使用字频</a>
<div id="wx_pic" style="margin:0 auto;display:none;">
<img src='/img/logo.png'/>
</div>
</center>
<h4 id="an-anatomists-tumor">An Anatomist’s Tumor</h4>
<p>151 It took plain old courage to be a chemotherapist: Vincent T.
DeVita Jr. and Edward Chu, “A History of Cancer Chemotherapy,” Cancer
Research 68, no. 21 (2008): 8643–53.</p>
<p>156 Hodgkin was born in 1798 to a Quaker family: Louis Rosenfeld,
Thomas Hodgkin: Morbid Anatomist andandandand Social Activist (Lanham,
MD: Madison Books, 1993), 1. Also see Amalie M. Kass and Edward H. Kass,
Perfecting the World: The Life and Times of Dr. Thomas Hodgkin,
1798–1866 (Boston: Harcourt Brace Jovanovich, 1988).</p>
<p>157 a series of cadavers, mostly of young men: T. Hodgkin, “On Some
Morbid Appearances of the Absorbent Glands and Spleen,”
Medico-Chirurgical Transactions 17 (1832): 68–114. The paper was read to
the society by Robert Lee because Hodgkin was not a member of the
society himself.</p>
<p>157 “A pathological paper may perhaps be thought”: Hodgkin, “On Some
Morbid Appearances,” 96.</p>
<p>157 In 1837, after a rather vicious political spat: Marvin J. Stone,
“Thomas Hodgkin: Medical Immortal and Uncompromising Idealist,” Baylor
University Medical Center Proceedings 18 (2005): 368–75.</p>
<p>157 In 1898, some thirty years after Hodgkin’s death: Carl Sternberg,
“Über eine eigenartige unter dem Bilde der Pseudoleu Kamie Verlaufende
Tuberkuloses des Lymphatischen Apparates,” Ztschr Heitt 19 (1898):
21–91.</p>
<p>158 more “capricious,” as one oncologist put it: A. Aisenberg,
“Prophylactic Radiotherapy in Hodgkin’s Disease,” New England Journal of
Medicine 278, no. 13 (1968): 740; A. Aisenberg, “Management of Hodgkin’s
Disease,” New England Journal of Medicine 278, no. 13 (1968): 739; A. C.
Aisenberg, “Primary Management of Hodgkin’s Disease,” New England
Journal of Medicine 278, no. 2 (1968): 92–95.</p>
<p>158 the plan to build a linear accelerator: Z. Fuks and M. Feldman,
“Henry S. Kaplan, 1918–1984: A Physician, a Scientist, a Friend,” Cancer
Surveys 4, no. 2 (1985): 294–311.</p>
<p>159 In 1953, he persuaded a team: Malcolm A. Bagshaw, Henry E. Jones,
Robert F. Kallman, and Joseph P. Kriss, “Memorial Resolution: Henry S.
Kaplan (1918–1984),” Stanford University Faculty Memorials, Stanford
Historical Society, http://histsoc.stanford.edu/pdfmem/KaplanH.pdf
(accessed November 22, 2009).</p>
<p>159 The accelerator was installed: Ibid.</p>
<p>159 “Henry Kaplan was Hodgkin’s disease”: George Canellos, interview
with author, March 2008.</p>
<p>159 Rene Gilbert had shown: R. Gilbert, “Radiology in Hodgkin’s
Disease [malignant granulomatosis]. Anatomic and Clinical Foundations,”
American Journal of Roentgenology and Radium Therapy 41 (1939): 198–241;
D. H. Cowan, “Vera Peters and the Curability of Hodgkin’s Disease,”
Current Oncology 15, no. 5 (2008): 206–10.</p>
<p>160 Peters observed that broad-field radiation could: M. V. Peters
and K. C. Middlemiss, “A Study of Hodgkin’s Disease Treated by
Irradiation,” American Journal of Roentgenology and Radium Therapy 79
(1958): 114–21.</p>
<p>160 The trials that Kaplan designed: H. S. Kaplan, “The Radical
Radiotherapy of Regionally Localized Hodgkin’s Disease,” Radiology 78
(1962): 553–61; Richard T. Hoppe, Peter T. Mauch, James O. Armitage,
Volker Diehl, and Lawrence M. Weiss, Hodgkin Lymphoma (Philadelphia:
Lippincott Williams andandandand Wilkins, 2007), 178.</p>
<p>160 “meticulous radiotherapy”: Aisenberg, “Primary Management of
Hodgkin’s Disease,” 95.</p>
<p>160 But Kaplan knew that a diminished relapse rate was not a cure: H.
S. Kaplan, “Radical Radiation for Hodgkin’s Disease,” New England
Journal of Medicine 278, no. 25 (1968): 1404; H. S. Kaplan, “Clinical
Evaluation and Radiotherapeutic Management of Hodgkin’s Disease and the
Malignant Lymphomas,” New England Journal of Medicine 278, no. 16
(1968): 892–99.</p>
<p>161 “Fundamental to all attempts at curative treatment”: Aisenberg,
“Primary Management of Hodgkin’s Disease,” 93.</p>
<h6 id="阅读日期-2026年01月16日-2026年01月16日-共-1-天">阅读日期：
2026年01月16日-2026年01月16日 共： 1 天</h6>
<script src="https://giscus.app/client.js"
        data-repo="hbaolong/hbaolong.github.io"
        data-repo-id="R_kgDOLetDQg"
        data-category="General"
        data-category-id="DIC_kwDOLetDQs4CfLEl"
        data-mapping="url"
        data-strict="0"
        data-reactions-enabled="1"
        data-emit-metadata="1"
        data-input-position="top"
        data-theme="preferred_color_scheme"
        data-lang="zh-CN"
        crossorigin="anonymous"
        async>
</script>
</body>
</html>
